SEC Tracker
Get the app

bioAffinity Technologies BIAF

bioAffinity Technologies announces CHEST 2026 presentation

Form
8-K
Filed
Importance
Routine
  1. October 15, 2026 press release
  2. Sponsors Learning Theater at CHEST 2026
  3. Discusses CyPath Lung for lung cancer risk stratification
  4. Highlights asthma/COPD test research data

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when bioAffinity Technologies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 8731 and related industry codes: the same peer list as the financial tables.

  1. IB Acquisition IBAC public float $15M, Mar 31, 2025, over 18 months old
  2. OneMedNet ONMD public float $14M, Jun 30, 2025
  3. 20/20 Biolabs AIDX
  4. Inotiv NOTV public float $71M, Mar 31, 2025, over 18 months old